Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Hans Lee

Pulmonary Disease Baltimore, MD Medical Doctor

NPI 1164637716 CMS profile 279569

1800 Orleans St, Sheikh Zayed Tower, Suite 125, Baltimore, MD 21287

Open in the dashboard

General payments

$277,246

395 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Hans Lee of Baltimore, MD is reported in the CMS Open Payments database as having received $277,246 across 395 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 98th percentile of Pulmonary Disease profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $30,991 43
2024 General $63,165 90
2023 General $50,776 91
2022 General $55,317 81
2021 General $8,503 10
2020 General $18,165 15
2019 General $50,329 65

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hans Lee
  • Pulmonary Disease median
  • Middle half of Pulmonary Disease
  • National median

In program year 2025, general payments to Hans Lee were reported at $30,991. Among 8,914 Pulmonary Disease profiles paid that year, the median was $500 and the middle half received between $124 and $1,893.

Show as a table
Year Hans Lee Pulmonary Disease median Middle half National median
2019 $50,329 $377 $109–$1,340 $163
2020 $18,165 $230 $56–$907 $114
2021 $8,503 $269 $68–$1,072 $132
2022 $55,317 $390 $100–$1,457 $149
2023 $50,776 $419 $114–$1,659 $160
2024 $63,165 $476 $123–$1,818 $164
2025 $30,991 $500 $124–$1,893 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Olympus Corporation of the Americas $143,126 208 payments
  2. Veran Medical Technologies, Inc. $55,546 41 payments
  3. Olympus America Inc. $35,808 53 payments
  4. Intuitive Surgical, Inc. $15,316 34 payments
  5. AstraZeneca Pharmaceuticals LP $5,735 16 payments
  6. Cook Incorporated $5,600 2 payments
  7. Olympus Medical Systems Corporation $5,550 5 payments
  8. Regeneron Pharmaceuticals, Inc. $4,000 1 payment
  9. Pinnacle Biologics, Inc $1,965 9 payments
  10. ERBE USA Inc $1,461 4 payments
  11. Other $3,141 22 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Education $128,526 66 payments
  2. Consulting Fee $101,850 51 payments
  3. Travel and Lodging $22,329 120 payments
  4. Food and Beverage $10,797 153 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $8,344 3 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $4,400 1 payment
  7. Honoraria $1,000 1 payment
Products named General payments · program years 2019–2025
  1. SINGLE USE SUCTION VALVE (Sterile) $116,667 148 payments
  2. Spin $51,054 33 payments
  3. Single Use Aspiration Needle $40,156 40 payments
  4. EVES EUS ULTRASOUND BRONCHOFIBERVIDEOSCOPE $33,681 32 payments
  5. Olympus $26,754 28 payments
  6. ViziShot 2 FLEX $26,345 18 payments
  7. EVIS EXERA II ULTRASONIC BRONCHOFIBERVIDEOSCOPE $15,805 22 payments
  8. Da Vinci Surgical System $15,316 34 payments
  9. Single Use Guide Sheath Kit $14,218 25 payments
  10. Single Use Aspiration Needle NA-U401SX $13,683 8 payments
  11. Other $30,293 67 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 44 billing codes

Paid by Medicare

$37,452

Medicare's payments for the services billed

Medicare patients

201

Average age 70

Services billed

379

120 women, 81 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
COPD 51%
Arthritis 48%
Ischemic heart disease 46%
Cancer 43%
Diabetes 35%
Chronic kidney disease 31%
Depression 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

395 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pulmonary Disease in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record